Skip to Content
Merck
All Photos(2)

Key Documents

860389P

Avanti

26:0-d4 Lyso PC

1-hexacosanoyl-d4-2-hydroxy-sn-glycero-3-phosphocholine, powder

Synonym(s):

1-hexacosanoyl(12,12,13,13-D4)-sn-glycero-3-phosphocholine

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C34H66D4NO7P
CAS Number:
Molecular Weight:
639.92
UNSPSC Code:
12352100
NACRES:
NA.25

Assay

>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)

form

powder

packaging

pkg of 1 × 1 mg (860389P-1mg)
pkg of 1 × 5 mg (860389P-5mg)

manufacturer/tradename

Avanti Research - A Croda Brand 860389P

shipped in

dry ice

storage temp.

−20°C

General description

26:0-d4 Lyso PC is a deuterated lysophosphatidylcholine (lyso pc) in which 4 protons of hexacosanoyl are replaced by deuterium.

Application

26:0-d4 Lyso PC has been used as an internal standard to extract total very long chain fatty acids (VLCFAs) from brain, testes and adrenal glands.

Packaging

5 mL Amber Glass Screw Cap Vial (860389P-1mg)
5 mL Amber Glass Screw Cap Vial (860389P-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Storage Class Code

11 - Combustible Solids


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Wedad Fallatah et al.
Disease models & mechanisms, 13(1) (2019-12-22)
Rhizomelic chondrodysplasia punctata (RCDP) is a rare genetic disorder caused by mutations in peroxisomal genes essential for plasmalogen biosynthesis. Plasmalogens are a class of membrane glycerophospholipids containing a vinyl-ether-linked fatty alcohol at the sn-1 position that affect functions including vesicular
Walter C Hubbard et al.
Molecular genetics and metabolism, 97(3), 212-220 (2009-05-09)
Newborn screening for X-linked adrenoleukodystrophy (X-ALD) has until now been limited in implementation because of the lack of an accepted standard methodology. We have previously reported a technique using LC-MS/MS analysis that could provide the basis for screening of newborns
A thyroid hormone-based strategy for correcting the biochemical abnormality in X-linked adrenoleukodystrophy
Hartley MD, et al.
Endocrinology, 158(5), 1328-1338 (2017)
John Williams et al.
Bioanalysis, 12(3), 143-158 (2020-02-14)
Aim: Very long chain fatty acids (VLCFAs) have been identified as biomarkers for several peroxisomal disorders necessitating the need for reliable biomarker assays in particular C20, C22, C24, C26 in cerebrospinal fluid (CSF). Until now no absolute quantitation assay for

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service